ÂÜÀòÂÒÂ×

Ymke Van Der Geld has a diverse work experience in the field of business development and management. Ymke has held senior positions in various organizations, starting with their role as Senior Director Business Development Europe at BioAgilytix since 2023. Prior to that, they served as the Director of Business Development at BioAgilytix Europe and Director of Business Development at Ardena Bioanalysis. Ymke also has experience as the CEO and Director of Business Development at BiomarkerBay, where they focused on biomarker assays and analysis. Ymke has also worked at Universitair Medisch Centrum Groningen (UMCG) as a Business Development Manager and Program Manager in clinical research. Ymke's earlier roles include Manager valorization and manager of the departments data release & dataintegrity at LifeLines and positions as a Research fellow and Project Manager at various organizations.

Ymke Van Der Geld earned their PhD in Medical Biology from the University of Groningen, starting in 1989 and completing their studies in 1995. Prior to that, they attended Nienoord college from 1983 to 1989. No degree or field of study information was provided for their time at Nienoord college.